This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Oct 1;51(7):867-8; author reply 868.

doi: 10.1086/656289.

Tigecycline and bacteremia--the dangers of post hoc analysis of pooled data

Giorgio Tarchini

PMID: 20809838
DOI: 10.1086/656289

Comment

Tigecycline and bacteremia--the dangers of post hoc analysis of pooled data

Giorgio Tarchini. Clin Infect Dis. 2010.

. 2010 Oct 1;51(7):867-8; author reply 868.

doi: 10.1086/656289.

Author

Giorgio Tarchini

PMID: 20809838
DOI: 10.1086/656289

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.
Gardiner D, Dukart G, Cooper A, Babinchak T. Gardiner D, et al. Clin Infect Dis. 2010 Jan 15;50(2):229-38. doi: 10.1086/648720. Clin Infect Dis. 2010. PMID: 20025527 Clinical Trial.

Similar articles

Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
Liou BH, Lee YT, Kuo SC, Liu PY, Fung CP. Liou BH, et al. Antimicrob Agents Chemother. 2015;59(6):3637-40. doi: 10.1128/AAC.04987-14. Epub 2015 Mar 30. Antimicrob Agents Chemother. 2015. PMID: 25824230 Free PMC article.
Tigecycline for treating bloodstream infections: a critical analysis of the available evidence.
Curcio D. Curcio D. Diagn Microbiol Infect Dis. 2008 Jul;61(3):358-9; author reply 360-1. doi: 10.1016/j.diagmicrobio.2008.01.025. Epub 2008 Mar 14. Diagn Microbiol Infect Dis. 2008. PMID: 18342476 No abstract available.
Multidrug-resistant Acinetobacter baumannii bacteremia treated with tigecycline in two pediatric burn patients.
Kanık-Yüksek S, Tezer H, Ozkaya-Parlakay A, Gulhan B, Sayed-Oskovi H, Kara A, Şenel E. Kanık-Yüksek S, et al. Pediatr Infect Dis J. 2015 Jun;34(6):677. doi: 10.1097/INF.0000000000000699. Pediatr Infect Dis J. 2015. PMID: 25970113 No abstract available.
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Garnacho-Montero J, Amaya-Villar R, Ferrándiz-Millón C, Díaz-Martín A, López-Sánchez JM, Gutiérrez-Pizarraya A. Garnacho-Montero J, et al. Expert Rev Anti Infect Ther. 2015 Jun;13(6):769-77. doi: 10.1586/14787210.2015.1032254. Epub 2015 Apr 12. Expert Rev Anti Infect Ther. 2015. PMID: 25865094 Review.
[Tigecycline: antimicrobial action, chemotherapeutic efficacy and adverse reactions].
Nikitin AV. Nikitin AV. Antibiot Khimioter. 2009;54(1-2):63-6. Antibiot Khimioter. 2009. PMID: 19499721 Review. Russian. No abstract available.

See all similar articles

Cited by

Excess deaths associated with tigecycline after approval based on noninferiority trials.
Prasad P, Sun J, Danner RL, Natanson C. Prasad P, et al. Clin Infect Dis. 2012 Jun;54(12):1699-709. doi: 10.1093/cid/cis270. Epub 2012 Mar 30. Clin Infect Dis. 2012. PMID: 22467668 Free PMC article.
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.
van Duin D, Kaye KS, Neuner EA, Bonomo RA. van Duin D, et al. Diagn Microbiol Infect Dis. 2013 Feb;75(2):115-20. doi: 10.1016/j.diagmicrobio.2012.11.009. Epub 2013 Jan 3. Diagn Microbiol Infect Dis. 2013. PMID: 23290507 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information